Promising Prospects: Hansoh Pharma's Class 1 Innovative Drugs, Ameile, Hansoh Xinfu and Fulaimei, Included in China’s National Reimbursement Drug List
Today (December 28), the National Healthcare Security Administration and the Ministry of Human Resources and Social Security of the PRC officially ann...
2020.12.28